Walid Macaron

1.3k citations
35 papers · 806 · 2 hit papers · h-index 15

Impact in

Papers in

Walid Macaron

33 papers receiving 802 citations

Walid Macaron's Hit Papers

Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML 2024 · 113 citations
1130+1+2Years since publication50100150

Peers

Walid Macaron
Comparison fields: 5 of 32
  • Hematology 362
  • Public Health, Environmental and Occupational Health 375
  • Oncology 54
  • Genetics 12
  • Cancer Research 15
Replace Eva E. Hoke with:
Eva E. Hoke United States
H-S Chi South Korea
Lirong Sun China
HM Lazarus United States
Masanobu Kasai Japan
Ravin Jain Garg United States
Weick Jk United States
Jeevan Kumar India
Ridhi Gupta United States
K Nishikawa Japan
Walid Macaron relative to Eva E. Hoke United States Eva E. Hoke's profile →
Citations per field
00.5×10×20×34.5×
Eva E. Hoke · 1×
Citations per year

Countries citing papers authored by Walid Macaron

Since Specialization
Citations

This map shows the geographic impact of Walid Macaron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walid Macaron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walid Macaron more than expected).

Fields of papers citing papers by Walid Macaron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walid Macaron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walid Macaron. The network helps show where Walid Macaron may publish in the future.

Co-authors

The 25 scholars most cited alongside Walid Macaron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Walid Macaron Line = papers co-authored together Walid Macaron links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial
Hit paper breakdown →
2022167
2
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML
Hit paper breakdown →
2024113
3 202284
4 202267
5 202353
6 202339
7 202235
8 202234
9 202227
10 202425
11 202223
12 202221
13 202218
14 202217
15 202215
16 202412
17 202210
18 202310
19 20228
20 20235

About Walid Macaron

Walid Macaron is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Oncology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 806 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (20 papers), Acute Myeloid Leukemia Research (12 papers), Chronic Myeloid Leukemia Treatments (2 papers), Cardiac tumors and thrombi (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Hematology (362 citations), Public Health, Environmental and Occupational Health (375 citations), Oncology (54 citations), Genetics (12 citations) and Cancer Research (15 citations). Walid Macaron has collaborated with scholars based in United States, Lebanon and France. Frequent co-authors include Nicholas James Short, Nitin Jain, Farhad Ravandi, Elias Joseph Jabbour, Hagop M. Kantarjian, Rebecca E. Garris, Musa E. Yilmaz, Tapan Mahendra Kadia, Marina Y Konopleva and Keyur Pravinchandra Patel. Their work appears in journals such as HemaSphere, Blood, American Journal of Hematology, Journal of Hematology & Oncology and The Lancet Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact